Empower Clinics sees 2Q revenue soar on the back of record patient growth

Empower Clinics sees 2Q revenue soar on the back of record patient growth

Proactive Investors

Published

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) posted second-quarter financial results on Tuesday that showed revenue grew 56% on the back of record patient growth at the company’s Sun Valley Health subsidiary, which owns a network of physician-staffed, health & wellness clinics in Oregon and Arizona. For the period ended June 30, 2020, the group clocked up revenue of $923,876 driven by 6,696 patient visits, compared to revenue of $591,023 based on 1,198 patient visits in the first quarter of 2019.  The group substantially lowered its net loss to $401,110 or $0.00 per share in the second quarter, compared to $1,456,506 or $0.01 per share for the same period in 2019 by reducing operating costs through aggressive headcount cuts, facility changes and a reduction in legal fees. Cash used in operating activities was $11,187 during the quarter, compared to $1,112,738 for the same period a year earlier. READ: Empower Clinics sees record patient visits and revenue per patient during July, boosted by coronavirus testing capabilities Empower also boosted its cash position at the end of June, 2020, to $305,935, compared to $179,152 on December 31, 2019. "Execution, operational excellence and a passion for patient care highlights a transformative quarter, in the midst of a pandemic," Empower Clinics CEO Steven McAuley said in a statement. "Our team continues to outperform, delivering triple-digit first-half 2020 growth, with continued diversification of services, setting in motion our ongoing path of growth," he added. For the six-month period ended June 30, 2020, the group posted revenue of $1,713,011 driven by 12,413 patient visits, compared to revenue of $743,869 based on 5,497 patient visits for the same period in 2019. The group’s net loss for the first half of the year also shrunk to $920,281 or $0.01 per share, compared to $1,855,047 or $0.02 per share for the six months ended June 30, 2019. Empower said it is booking new physician appointments for immune-boosting services that are leading to naturopathic product sales and the ordering of specialized tests. The company also offers coronavirus (COVID-19) testing in clinics and onsite for businesses. Contact the author Uttara Choudhury at uttara@proactiveinvestors.com Follow her on Twitter: @UttaraProactive

Full Article